Biogen Idec (NASDAQ:BIIB)

Biotechnology word cloud

Short Sellers Increase Their Bets Against Biotech Stocks

The short interest data are out for the March 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Biotechnology word cloud

RBC Has 4 Biotech Stocks to Buy After Massive Pullback

The XBI, which is the S&P 500 biotech index, has been hit hard this week and is down almost 14% since last Friday. While still up big over the past ...
Read Full Story »
Stock Split Image

7 Companies That Seriously Should Split Their Stocks

The bull market is now six years old, and the Dow Jones Industrial Average (DJIA) and S&P 500 have bounced an average of about 200% each from the March 2009 ...
Read Full Story »
research

Major Biotech Is So-So for Short Sellers

The short interest data are out for the March 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples, Tyco and More

Stocks were indicated marginally lower and were still looking for direction Monday morning. Still, the S&P 500 was above 2,100 and the Dow Jones Industrial Average was above 18,100 after ...
Read Full Story »
152498601

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

Over 5 million Americans are currently living with Alzheimer’s disease, and it is the sixth leading cause of death in the United States, according to the Alzheimer’s Association. Alzheimer’s, along ...
Read Full Story »
Euro

How the Weaker Euro Is Impacting Biotech Earnings

It is no secret that a strong dollar and a weak euro, and foreign currency environment, are acting to hurt U.S. corporate earnings. Many investors might think that biotech earnings ...
Read Full Story »
DNA

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech companies could have some very import clinical data releases. A ...
Read Full Story »
Biotechnology word cloud

Short Sellers Get More Aggressive on Big Biotech

The short interest data are out for the February 27 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
Money background. Close-up.

9 Well-Established Companies That Just Refuse to Pay Dividends

Investors are still in love with dividends. After all, dividends can account for a large portion of total returns through time. With a bull market that is now six years old, ...
Read Full Story »
biotech

The 5 Most Loved Biotech Stocks of Portfolio Managers

With the market continuing to grind higher, and the memories of the first time the Nasdaq hit 5,000 getting a fair amount of airplay and commentary, the question for most ...
Read Full Story »
research

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The short interest data are out for the February 13 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
buy sell

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Investors have all-time highs to cheer for the S&P 500 Index and in the Dow Jones Industrial Average, but not yet in the Nasdaq. After a nine-day rally, Nasdaq stocks as ...
Read Full Story »
biotech

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Since the beginning of the year, there has been a flood of biotech initial public offerings (IPOs) and secondaries, and the market has become so oversaturated that some of the ...
Read Full Story »
Biotechnology word cloud

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »